Alex Gutterres Taranto (Alex G Taranto)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Topics

Cognitive Decline

Oxide Nanoparticles

Molecular Dynamics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of biomolecular structure & dynamics

Oxidative medicine and cellular longevity

Journal of tropical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Géssica Oliveira Mendes, Samuel Silva da Rocha Pita, Paulo Batista de Carvalho, Michel Pires da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and β -Secretase 1: Next Generation for Alzheimer's Disease Treatment. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Géssica Oliveira Mendes, Moysés Fagundes de Araújo Neto, Deyse Brito Barbosa, Mayra Ramos do Bomfim, Lorena Silva Matos Andrade, Paulo Batista de Carvalho, Tiago Alves de Oliveira, Daniel Luciano Falkoski, Eduardo Habib Bechelane Maia, Marcelo Siqueira Valle, Laila Cristina Moreira Damázio, Alisson Marques da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Deyse Brito Barbosa, Mayra R do Bomfim, Tiago Alves de Oliveira, Alisson Marques da Silva, Alex Gutterres Taranto, Jorddy Nevez Cruz, Paulo Batista de Carvalho, Joaquín Maria Campos Rosa, Cleydson Breno Rodrigues Dos Santos, Franco H A Leite
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Géssica Oliveira Mendes, Samuel Silva da Rocha Pita, Paulo Batista de Carvalho, Michel Pires da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and β -Secretase 1: Next Generation for Alzheimer's Disease Treatment. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Deyse Brito Barbosa, Mayra R do Bomfim, Tiago Alves de Oliveira, Alisson Marques da Silva, Alex Gutterres Taranto, Jorddy Nevez Cruz, Paulo Batista de Carvalho, Joaquín Maria Campos Rosa, Cleydson Breno Rodrigues Dos Santos, Franco H A Leite
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Géssica Oliveira Mendes, Moysés Fagundes de Araújo Neto, Deyse Brito Barbosa, Mayra Ramos do Bomfim, Lorena Silva Matos Andrade, Paulo Batista de Carvalho, Tiago Alves de Oliveira, Daniel Luciano Falkoski, Eduardo Habib Bechelane Maia, Marcelo Siqueira Valle, Laila Cristina Moreira Damázio, Alisson Marques da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Mayra Ramos do Bomfim, Deyse Brito Barbosa, Paulo Batista de Carvalho, Alisson Marques da Silva, Tiago Alves de Oliveira, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Identification of potential human beta-secretase 1 inhibitors by hierarchical virtual screening and molecular dynamics. Journal of biomolecular structure & dynamics (2022)
Tiago Alves de Oliveira, Lucas Rolim Medaglia, Eduardo Habib Bechelane Maia, Letícia Cristina Assis, Paulo Batista de Carvalho, Alisson Marques da Silva, Alex Gutterres Taranto
Evaluation of Docking Machine Learning and Molecular Dynamics Methodologies for DNA-Ligand Systems. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
David Bacelar Costa Júnior, Janay Stefany Carneiro Araújo, Larissa de Mattos Oliveira, Flávio Simas Moreira Neri, Paulo Otávio Lourenço Moreira, Alex Gutterres Taranto, Amanda Luisa da Fonseca, Fernando de Pilla Varotti, Franco Henrique Andrade Leite
A novel antiplasmodial compound: integration of in silico and in vitro assays. Journal of biomolecular structure & dynamics (2021)
David Bacelar Costa Júnior, Janay Stefany Carneiro Araújo, Larissa de Mattos Oliveira, Flávio Simas Moreira Neri, Paulo Otávio Lourenço Moreira, Alex Gutterres Taranto, Amanda Luisa da Fonseca, Fernando de Pilla Varotti, Franco Henrique Andrade Leite
Identification of novel antiplasmodial compound by hierarquical virtual screening and in vitro assays. Journal of biomolecular structure & dynamics 39 (9) (2020)
Renata Rachide Nunes, Amanda Luisa da Fonseca, Ana Claudia de Souza Pinto, Eduardo Habib Bechelane Maia, Alisson Marques da Silva, Fernando de Pilla Varotti, Alex Gutterres Taranto
Brazilian malaria molecular targets (BraMMT): selected receptors for virtual high-throughput screening experiments. Memorias do Instituto Oswaldo Cruz 114 (2019)
Bruna Celeida Silva Santos, Andressa Soares Pires, Célia Hitomi Yamamoto, Mara Rubia Costa Couri, Alex Gutterres Taranto, Maria Silvana Alves, Ana Lúcia Dos Santos de Matos Araújo, Orlando Vieira de Sousa
Methyl Chavicol and Its Synthetic Analogue as Possible Antioxidant and Antilipase Agents Based on the In Vitro and In Silico Assays. Oxidative medicine and cellular longevity 2018 (2018)
Tatiane Freitas Borgati, Maria Fernanda Alves do Nascimento, Juma Fortunato Bernardino, Lunamaura Claudia Oliveira Martins, Alex Gutterres Taranto, Alaíde Braga de Oliveira
Synthesis, SAR, and Docking Studies Disclose 2-Arylfuran-1,4-naphthoquinones as In Vitro Antiplasmodial Hits. Journal of tropical medicine 2017 (2017)